Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 251.55
-17.10 (-6.37%)
At close: Mar 27, 2026
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 27.41 billion as of March 27, 2026. Its market cap has decreased by -4.17% in one year.
Market Cap
27.41B
Enterprise Value
28.02B
Revenue
1.59B
Ranking
n/a
PE Ratio
57.36
Stock Price
251.55
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 27.41B, an increase of 78,665.18%. That is a compound annual growth rate of 31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 27.41B | -43.15% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 154.88B |
| Shilpa Medicare | 68.44B |
| Suven Life Sciences | 34.28B |
| IOL Chemicals and Pharmaceuticals | 22.87B |
| NGL Fine-Chem | 13.11B |
| Bajaj HealthCare | 9.50B |
| Anlon Healthcare | 6.16B |
| Shree Ganesh Remedies | 5.67B |